Advanced technology has enabled the detection of changes in fentanyl consumption earlier than conventional reporting systems. A company based in Cambridge, Massachusetts, Biobot Analytics, disclosed new research results on June 24, 2026. The study, funded by NIH/NIDA, highlighted the capability of monitoring wastewater to predict trends in drug use. This innovative approach allows for the identification of shifts in fentanyl usage several months in advance compared to traditional methods. Biobot Analytics is recognized as a pioneer in leveraging wastewater data for insightful analysis.